Home » Clinical Trials » Search Clinical Trials Therapeutic Areas: Dermatology | Family Medicine
Dermatitis, Atopic Clinical Trials
A listing of Dermatitis, Atopic medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.
Filter by:
Phase:
All
N/A
0
1
1/2
2
2/3
3
4
Gender:
Both
Male
Female
Age:
Location:
All
US: Alabama
US: Alaska
US: Arizona
US: Arkansas
US: California
US: Colorado
US: Connecticut
US: Delaware
US: District of Columbia
US: Florida
US: Georgia
US: Hawaii
US: Idaho
US: Illinois
US: Indiana
US: Iowa
US: Kansas
US: Kentucky
US: Louisiana
US: Maine
US: Maryland
US: Massachusetts
US: Michigan
US: Minnesota
US: Mississippi
US: Missouri
US: Montana
US: Nebraska
US: Nevada
US: New Hampshire
US: New Jersey
US: New Mexico
US: New York
US: North Carolina
US: North Dakota
US: Ohio
US: Oklahoma
US: Oregon
US: Pennsylvania
US: Rhode Island
US: South Carolina
US: South Dakota
US: Tennessee
US: Texas
US: Utah
US: Vermont
US: Virgin Islands
US: Virginia
US: Washington
US: West Virginia
US: Wisconsin
US: Wyoming
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island And Mcdonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts And Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome And Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard And Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad And Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis And Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
First 1 2 3 4 Last
Alabama
Birmingham Alabama 35233
A Phase 2 clinical study for patients with Atopic Dermatitis
Birmingham (2 locations) Alabama Updated
A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis
Mobile Alabama Updated
A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis
Mobile Alabama 36608
Patients are needed to participate in a clinical research study evaluating OPA-15406, Tacrolimus and Placebo for the treatment of Atopic Dermatitis
Arizona
Hot Springs Arizona 71913
Patients are needed to participate in a clinical research study evaluating OPA-15406, Tacrolimus and Placebo for the treatment of Atopic Dermatitis
Tucson Arizona Updated
A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis
California
Bakersfield California Updated
A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis
Call for Information (Investigational Site 0028)
A clinical trial to evaluate treatments using MK-8226 and Placebo for patients with Atopic Dermatitis
Encino California 91436
A Phase 2 clinical study for patients with Atopic Dermatitis
Oceanside California 92056
A Phase 2 clinical study for patients with Atopic Dermatitis
UCSD - Rady Children's Hospital
A Phase 2 clinical study for patients with Atopic Dermatitis
View More »
San Diego California 92122
A Phase 2 clinical study for patients with Atopic Dermatitis
San Diego (2 locations) California Updated
A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis
Santa Monica California Updated
A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis
Colorado
Call for Information (Investigational Site 0010)
A clinical trial to evaluate treatments using MK-8226 and Placebo for patients with Atopic Dermatitis
Denver Colorado 80220
A Phase 2 clinical study for patients with Atopic Dermatitis
Florida
Jacksonville Florida 32204
A Phase 2 clinical study for patients with Atopic Dermatitis
Jacksonville (2 locations) Florida Updated
A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis
Miami Florida 33144
A Phase 2 clinical study for patients with Atopic Dermatitis
Miami Florida 33175
A Phase 2 clinical study for patients with Atopic Dermatitis
Miramar Florida 33207
A Phase 2 clinical study for patients with Atopic Dermatitis
View More »
Orange Park Florida 32073
Patients are needed to participate in a clinical research study evaluating OPA-15406, Tacrolimus and Placebo for the treatment of Atopic Dermatitis
Ormond Beach Florida Updated
A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis
Tampa Florida 33609
A Phase 2 clinical study for patients with Atopic Dermatitis
Tampa Florida 33613
A Phase 2 clinical study for patients with Atopic Dermatitis
Tampa Florida 33609
Patients are needed to participate in a clinical research study evaluating OPA-15406, Tacrolimus and Placebo for the treatment of Atopic Dermatitis
Idaho
Boise Idaho 83704
A Phase 2 clinical study for patients with Atopic Dermatitis
Illinois
Arlington Heights Illinois 60025
Patients are needed to participate in a clinical research study evaluating HL-009 Liposomal Gel for the treatment of Mild to Moderate Atopic Dermatitis
Northwestern University, Department of Dermatology
A clinical trial seeking patients for a research study for the treatment of Eczema or Atopic Dermatitis
Northwestern University
A Phase 2 clinical study for patients with Atopic Dermatitis
Sneeze, Wheeze & Itch Associates, LLC
A Phase 2 clinical study for patients with Atopic Dermatitis
Skokie Illinois Updated
A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis
Indiana
Carmel Indiana 46032
Patients are needed to participate in a clinical research study evaluating OPA-15406, Tacrolimus and Placebo for the treatment of Atopic Dermatitis
Louisiana
New Orleans Louisiana Updated
A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis
Massachusetts
Andover Massachusetts Updated
A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis
Boston (2 locations) Massachusetts Updated
A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis
Michigan
Fort Gratiot Michigan 48059
A Phase 2 clinical study for patients with Atopic Dermatitis
Troy Michigan Updated
A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis
Minnesota
Minnesota Clinical Study Center
A Phase 2 clinical study for patients with Atopic Dermatitis
Fridley Minnesota 55432
Patients are needed to participate in a clinical research study evaluating HL-009 Liposomal Gel for the treatment of Mild to Moderate Atopic Dermatitis
Missouri
St. Louis Missouri Updated
A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis
New Jersey
Berlin New Jersey 08009
Patients are needed to participate in a clinical research study evaluating HL-009 Liposomal Gel for the treatment of Mild to Moderate Atopic Dermatitis
Berlin New Jersey 08009
Patients are needed to participate in a clinical research study evaluating OPA-15406, Tacrolimus and Placebo for the treatment of Atopic Dermatitis
Verona New Jersey 07044
A Phase 2 clinical study for patients with Atopic Dermatitis
New Mexico
Academic Dermatology Associates
A Phase 2 clinical study for patients with Atopic Dermatitis
New York
New York New York Updated
A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis
Call for Information (Investigational Site 0002)
A clinical trial to evaluate treatments using MK-8226 and Placebo for patients with Atopic Dermatitis
Rochester (2 locations) New York Updated
A clinical research study of Dupilumab (REGN668/ SAR231893) and Placebo for the treatment of Atopic Dermatitis
Stony Brook New York 11790
A Phase 2 clinical study for patients with Atopic Dermatitis
North Carolina
Dermatology Consulting Services
A Phase 2 clinical study for patients with Atopic Dermatitis
First 1 2 3 4 Last
